Literature DB >> 16647867

Retinoic acid-induced protein ISGylation is dependent on interferon signal transduction.

Chinh T Dao1, Jiann-Kae Luo, Dong-Er Zhang.   

Abstract

Interferon-stimulated gene 15 (ISG15) is a ubiquitin-like modifier that forms conjugates with target protein substrates. As its name suggests, its expression and conjugation to other proteins are highly regulated by interferon (IFN). It was recently demonstrated that ISG15 expression, ISG15 conjugation, and several enzymes involved in ISG15 modification are upregulated in an acute promyelocytic cell line following treatment with retinoic acid, suggesting a possible retinoic acid induced IFN-independent ISG15 modification pathway. In this study, we examined a possible link between IFN signaling and retinoic acid-induced ISG15 conjugation. We observed that ISGylation can be induced by retinoic acid in two myeloid leukemia cell lines. By sandwich ELISA, we detected increased IFN secretion into cell culture media following retinoic acid treatment. Blockade of the type I IFN receptor with a neutralizing antibody blocked retinoic acid induced ISG15 expression and ISG15 conjugation. Taken together, these data suggested that retinoic acid-induced secretion of IFN plays a fundamental role in retinoic acid promoted ISGylation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16647867     DOI: 10.1016/j.bcmd.2006.02.005

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  9 in total

Review 1.  Viral defense, carcinogenesis and ISG15: novel roles for an old ISG.

Authors:  Ian F Pitha-Rowe; Paula M Pitha
Journal:  Cytokine Growth Factor Rev       Date:  2007-08-03       Impact factor: 7.638

Review 2.  Interferon-stimulated gene 15 and the protein ISGylation system.

Authors:  Dongxian Zhang; Dong-Er Zhang
Journal:  J Interferon Cytokine Res       Date:  2010-12-29       Impact factor: 2.607

3.  ISG15 as a novel tumor biomarker for drug sensitivity.

Authors:  Shyamal D Desai; Laurence M Wood; Yu-Chen Tsai; Tao-Shih Hsieh; Jeffrey R Marks; Georgia L Scott; Beppino C Giovanella; Leroy F Liu
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

4.  Knockout of the Bcmo1 gene results in an inflammatory response in female lung, which is suppressed by dietary beta-carotene.

Authors:  Yvonne G J van Helden; Sandra G Heil; Frederik J van Schooten; Evelien Kramer; Susanne Hessel; Jaume Amengual; Joan Ribot; Katja Teerds; Adrian Wyss; Georg Lietz; M Luisa Bonet; Johannes von Lintig; Roger W L Godschalk; Jaap Keijer
Journal:  Cell Mol Life Sci       Date:  2010-04-06       Impact factor: 9.261

5.  UBE1L represses PML/RAR{alpha} by targeting the PML domain for ISG15ylation.

Authors:  Sumit J Shah; Steven Blumen; Ian Pitha-Rowe; Sutisak Kitareewan; Sarah J Freemantle; Qing Feng; Ethan Dmitrovsky
Journal:  Mol Cancer Ther       Date:  2008-04       Impact factor: 6.261

6.  Hepatitis C Virus Evasion from RIG-I-Dependent Hepatic Innate Immunity.

Authors:  Helene Minyi Liu; Michael Gale
Journal:  Gastroenterol Res Pract       Date:  2011-01-17       Impact factor: 2.260

7.  Covalent ISG15 conjugation positively regulates the ubiquitin E3 ligase activity of parkin.

Authors:  Eunju Im; Lang Yoo; Minju Hyun; Woo Hyun Shin; Kwang Chul Chung
Journal:  Open Biol       Date:  2016-08       Impact factor: 6.411

Review 8.  ISG15 and ISGylation in Human Diseases.

Authors:  Oygul Mirzalieva; Meredith Juncker; Joshua Schwartzenburg; Shyamal Desai
Journal:  Cells       Date:  2022-02-04       Impact factor: 7.666

9.  Inhibition of UBE2L6 attenuates ISGylation and impedes ATRA-induced differentiation of leukemic cells.

Authors:  Nina Orfali; Deborah Shan-Krauer; Tracey R O'Donovan; Nigel P Mongan; Lorraine J Gudas; Mary R Cahill; Mario P Tschan; Sharon L McKenna
Journal:  Mol Oncol       Date:  2020-05-01       Impact factor: 6.603

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.